Skip Navigation

Your Environment. Your Health.

Therapeutic Studies

Therapeutic Studies: These are trials in adult and/or juvenile myositis being conducted by investigators that are affiliated with IMACS. Many of these trials are planning to contribute their data to the IMACS Outcomes Repository upon completion. For further information about each study, please contact the study's principal investigator.


Collaborative therapeutic trials that are conducted under the auspices of the IMACS Group are those that involve a number of IMACS investigators and have also been reviewed by the IMACS coordinators.


Methotrexate in Polymyositis and Dermatomyositis


Treatment with Interleukin-1 Receptor Antagonist (IL-1ra) in Patients with Chronic Inflammatory Myopathies


Rituximab in Adult Polymyositis and Dermatomyositis and Juvenile Dermatomyositis


B cell depletion in Idiopathic Inflammatory Myopathy


Rituximab in Dermatomyositis


Etanercept in Adult Dermatomyositis


Infliximab in Polymyositis and Dermatomyositis


Infliximab in Polymyositis/Dermatomyositis/Inclusion Body Myositis


A longitudinal, integrated clinical, histological and mRNA profiling study of resistance exercise in myositis


Submit Your Study Information


IMACS members who would like to post information about their study should submit their listing to the IMACS coordinators to include the following information:


Study Title:
Principal Investigator:
Study Hypothesis:
Study Design:
Types & Number of IIM Studied:
Entry Criteria:
IMACS Core Set Measures Included:
Other Measures Included:
Primary Outcome:
Secondary Outcomes:
Key Trial Dates: Date of Registration, Start of Enrollment, Anticipated Completion
Funding Sources:

Back to Top